NEO
NEO
NASDAQ · Health Care

Neogenomics Inc

$15.31
+0.06 (+0.39%)
As of Nov 18, 7:05 PM ET ·
Financial Highlights (FY 2026)
Revenue
763.74M
Net Income
-113,434,811
Gross Margin
43.2%
Profit Margin
-14.9%
Rev Growth
+12.6%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 763.74M 678.40M 759.46M 804.45M
Gross Profit 330.01M 293.13M 380.80M 403.36M
Operating Income -121,663,447 -97,261,593 67.00M 69.80M
Net Income -113,434,811 -90,683,362 56.53M 50.19M
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Rev Growth +12.6% +12.6% -7.8% -8.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 310.40M 310.40M 99.64M 90.17M
Total Equity 759.66M 759.66M 945.36M 961.54M
D/E Ratio 0.41 0.41 0.11 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -84,164,782 -71,021,978 95.37M 98.54M
Free Cash Flow — — 21.30M 34.74M